Win up to 100% Scholarship

Register Now

The Countdown to a WHO Pandemic Treaty: Key Features

The Countdown to a WHO Pandemic Treaty: Key Features

Context

The ninth session of the Intergovernmental Negotiating Body (INB), marking the concluding phase of discussions for the World Health Organization Pandemic Agreement, began recently.

Relevancy for Prelims: World Health Organization (WHO), Global Initiative On Digital Health (GIDH), Global TB Report 2023 and, CoViNet- A Global Laboratory To Monitor

Relevancy for Mains: WHO Pandemic Treaty: Key Features, Concerns, and Way Forward.

WHO Pandemic Treaty: WHO Member States Agree to Resume Negotiations Aimed at Finalizing the World’s First Pandemic Agreement

  • Background of WHO Pandemic Treaty: In March 2021, an extraordinary call for a pandemic treaty was issued by 25 heads of government and international agencies, marking a pivotal moment in global health governance.

The key features of WHO Pandemic Treaty

  • Establishment of the COP: 

    • The current negotiating texts have also proposed an establishment of the Conference of Parties (COP) to oversee the implementation of the WHO Pandemic Agreement.
  • International Treaty: 

    • The proposed establishment of a COP suggests that an agreement could be a classic international treaty adopted under Article 19 of the WHO Constitution as opposed to the alternative Article 21 opt-out regulations.
  • Pathogen Access and Benefit-Sharing (PABS): 

    • To address this issue, the current draft of the Agreement proposes a quid pro quo mechanism, formally titled the WHO PABS System.
      • It compels countries to share genome sequence information and samples with WHO-coordinated networks and databases.
      • In return for access to this data, manufacturers will be required to provide 10% of their products free of charge and 10% at not-for-profit prices.
    • The current text of the provision aims to establish legal obligations on benefits-sharing for all users of biological materials and genetic sequence data under PABS.
      • A robust PABS system, particularly for low- and middle- income countries, including some African nations, seems non-negotiable for promoting equity in access to medical countermeasures.

Concerns with the Treaty

  • Access and benefit sharing: Many developed countries and the pharmaceutical industry are not satisfied  with access and benefit sharing in the current negotiating text, including the perceived trade-offs.
  • Hesitancy to Share information: The agreement involves the establishment of a global system for sharing pathogens and their genetic codes but developing countries are hesitant to share information on pathogen spread and evolution if they perceive little in return, a situation exacerbated during the COVID-19 pandemic by vaccine nationalism.
  • Enforcement Mechanisms: The effectiveness of the Agreement could be compromised in the absence of a strong enforcement mechanism.
  •  Limitations of International Health Regulations: The existing International Health Regulations are already legally binding. However, they failed to prevent unjust travel or trade restrictions, and hoarding of vaccines and other medical countermeasures during the COVID-19 pandemic.

Conclusion

The WHO Pandemic treaty/ agreement represents a critical step towards rebuilding trust and coordination between nations, acknowledging that no single Government or institution can confront the threat of future pandemics in isolation.

Also Read: India TB Report 2024

 

Prelims PYQ (2021):

With reference to recent developments regarding ‘Recombinant Vector Vaccine’, consider the following statements: 

1. Genetic engineering is applied in the development of these vaccines. 

2. Bacteria and viruses are used as vectors. 

Which of the statements given above is/are correct? 

(a) 1 only 

(b) 2 only 

(c) Both 1 and 2 

(d) Neither 1 nor 2

Ans: (c)

 

Mains Question: Explain the key areas of debate surrounding the WHO Pandemic Treaty. Analyse the divergences between developed and developing nations on issues such as intellectual property rights and equitable vaccine distribution. (15 M, 250 Words)

 

Must Read
NCERT Notes For UPSC UPSC Daily Current Affairs
UPSC Blogs UPSC Daily Editorials
Daily Current Affairs Quiz Daily Main Answer Writing
UPSC Mains Previous Year Papers UPSC Test Series 2024

 

To get PDF version, Please click on "Print PDF" button.

 Final Result – CIVIL SERVICES EXAMINATION, 2023.   Udaan-Prelims Wallah ( Static ) booklets 2024 released both in english and hindi : Download from Here!     Download UPSC Mains 2023 Question Papers PDF  Free Initiative links -1) Download Prahaar 3.0 for Mains Current Affairs PDF both in English and Hindi 2) Daily Main Answer Writing  , 3) Daily Current Affairs , Editorial Analysis and quiz ,  4) PDF Downloads  UPSC Prelims 2023 Trend Analysis cut-off and answer key

THE MOST
LEARNING PLATFORM

Learn From India's Best Faculty

      

 Final Result – CIVIL SERVICES EXAMINATION, 2023.   Udaan-Prelims Wallah ( Static ) booklets 2024 released both in english and hindi : Download from Here!     Download UPSC Mains 2023 Question Papers PDF  Free Initiative links -1) Download Prahaar 3.0 for Mains Current Affairs PDF both in English and Hindi 2) Daily Main Answer Writing  , 3) Daily Current Affairs , Editorial Analysis and quiz ,  4) PDF Downloads  UPSC Prelims 2023 Trend Analysis cut-off and answer key

Quick Revise Now !
AVAILABLE FOR DOWNLOAD SOON
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध
Quick Revise Now !
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध

<div class="new-fform">







    </div>

    Subscribe our Newsletter
    Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
    *Promise! We won't spam you.
    Yes! I want to Subscribe.